NCEL Latest Press Releases

-- September 28, 2026 --

NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes Globe Newswire 8:00 AM

-- July 31, 2026 --

NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing Globe Newswire 9:00 AM

-- July 15, 2026 --

NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio Globe Newswire 9:00 AM

-- July 8, 2026 --

NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board Globe Newswire 9:15 AM

The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy PRNewswire 9:01 AM

-- July 1, 2026 --

NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes Globe Newswire 9:30 AM

-- June 15, 2026 --

NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform Globe Newswire 8:30 AM

-- May 27, 2026 --

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes Globe Newswire 7:55 AM

-- April 30, 2026 --

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 Globe Newswire 8:15 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software